Cargando…
Activity-Based Proteomics Reveals Heterogeneous Kinome and ATP-Binding Proteome Responses to MEK Inhibition in KRAS Mutant Lung Cancer
One way cancer cells can escape from targeted agents is through their ability to evade drug effects by rapidly rewiring signaling networks. Many protein classes, such as kinases and metabolic enzymes, are regulated by ATP binding and hydrolysis. We hypothesized that a system-level profiling of drug-...
Autores principales: | Kim, Jae-Young, Stewart, Paul A., Borne, Adam L., Fang, Bin, Welsh, Eric A., Chen, Yian Ann, Eschrich, Steven A., Koomen, John M., Haura, Eric B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217344/ https://www.ncbi.nlm.nih.gov/pubmed/28154798 http://dx.doi.org/10.3390/proteomes4020016 |
Ejemplares similares
-
Kinome-wide identification of phosphorylation networks in eukaryotic proteomes
por: Parca, Luca, et al.
Publicado: (2019) -
Synergistic activity and heterogeneous acquired resistance of combined MDM2 and MEK inhibition in KRAS mutant cancers
por: Hata, Aaron N, et al.
Publicado: (2017) -
Chemical Proteomic Analysis
Reveals the Drugability
of the Kinome of Trypanosoma brucei
por: Urbaniak, Michael D., et al.
Publicado: (2012) -
Mutant KRAS-Associated Proteome Is Mainly Controlled by Exogenous Factors
por: Dias Carvalho, Patrícia, et al.
Publicado: (2022) -
The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer
por: Diehl, J. Nathaniel, et al.
Publicado: (2021)